MX9707121A - Formulaciones liquidas de gch. - Google Patents
Formulaciones liquidas de gch.Info
- Publication number
- MX9707121A MX9707121A MX9707121A MX9707121A MX9707121A MX 9707121 A MX9707121 A MX 9707121A MX 9707121 A MX9707121 A MX 9707121A MX 9707121 A MX9707121 A MX 9707121A MX 9707121 A MX9707121 A MX 9707121A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- liquid formulations
- stabilised
- hcg
- hcg liquid
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
La invencion se refiere a composiciones farmacéuticas, liquidas que contienen GCH estabilizada con un polialcohol o un azucar no reductor. De preferencia, las composiciones son estabilizadas con manitol. En las modalidades preferidas tales composiciones son soluciones acuosas en una solucion amortiguadora de fosfato con un pH de 7. Tales composiciones están listas para ser inyectadas y, por lo tanto, la etapa de reconstitucion del polvo liofilizado se evita, de esta forma simplificando la forma de uso.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX9707121A MX9707121A (es) | 1997-09-19 | 1997-09-19 | Formulaciones liquidas de gch. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX9707121A MX9707121A (es) | 1997-09-19 | 1997-09-19 | Formulaciones liquidas de gch. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9707121A true MX9707121A (es) | 1998-06-30 |
Family
ID=39491358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9707121A MX9707121A (es) | 1997-09-19 | 1997-09-19 | Formulaciones liquidas de gch. |
Country Status (1)
Country | Link |
---|---|
MX (1) | MX9707121A (es) |
-
1997
- 1997-09-19 MX MX9707121A patent/MX9707121A/es unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL133220A0 (en) | Stabilized antibody formulation | |
UA26855C2 (uk) | Фармацевтичhа композиція, яка регулює гематопоез | |
MXPA03000046A (es) | Interleucina-2 estabilizada. | |
PL313084A1 (en) | Pharmaceutic formulation of nerve growth factor | |
IL106750A0 (en) | Peg interferon conjugates | |
HU9401831D0 (en) | Stabilized pharmaceutical formulations comprising growth hormone and asparagine | |
EP0454044A3 (en) | Pharmacological product containing polyelectrolyte complexes in microparticulate form and at least one substance | |
HUP0100090A2 (hu) | Szájápoló készítmények | |
IE891032L (en) | Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation | |
MX9603515A (es) | Preparacion farmaceutica que contiene activadores de plasminogeno. | |
AU2670495A (en) | Ifn-beta liquid formulations | |
WO2001045650A3 (de) | Kosmetische verwendung von rückständen aus der weinherstellung | |
IE880183L (en) | Thrombin preparations | |
ATE157256T1 (de) | Il-6 enthaltende pharmazeutische zusammensetzungen stabilisiert mit einem nicht- reduzierenden zucker | |
PL340731A1 (en) | Single-dose syringe of less than 0.5 ml cubic content containing lyophilised protein composition | |
MX9707121A (es) | Formulaciones liquidas de gch. | |
MY123805A (en) | Stabilized pharmaceutical composition based on quinupristine and dalfopristine and their preparation. | |
ES8501982A1 (es) | Un procedimiento para obtener una composicion farmaceutica liofilizada a base de interferon y un aminoacido estabilizante. |